Exabis Library
Welcome to the e-CCO Library!
OP12: The incidence and disease course of Perianal Crohn’s Disease - A Danish nationwide cohort study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
OP12: The incidence and disease course of Perianal Crohn’s Disease - A Danish nationwide cohort study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP13 Glyco-fingerprint as a relevant risk factor on colitis-associated cancer
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP13: Anti-integrin ⍺vβ6 autoantibodies are increased in PSC-IBD and correlate with liver disease severity
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
OP13: Glyco-fingerprint as a relevant risk factor on colitis-associated cancer
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
OP13: Glyco-fingerprint as a relevant risk factor on colitis-associated cancer
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP13: Modified 2-stage vs. 3-stage ileal pouch-anal anastomosis result in equivalent long-term functional outcomes and pouch survival: A matched-pair analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI phase 3 induction study
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI Phase 3 induction study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP13: Mucosal organoids capture Innate Lymphoid Cells (ILC) tissue-specific development and reveal that Inflammatory Bowel Disease-associated ILC modulate intestinal remodelling
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP13: Mucosal organoids capture Innate Lymphoid Cells (ILC) tissue-specific development and reveal that Inflammatory Bowel Disease-associated ILC modulate intestinal remodelling
2021
ECCO'21 Virtual
Friday, 1 October 2021, 12:41 PM
OP13: Postoperative Crohn's disease recurrence: unanswered questions and future directions in diagnosis, pathophysiology, prevention and treatment. Conclusions from the 8th ECCO Scientific workshop.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP13: Postoperative Crohn’s disease recurrence: unanswered questions and future directions in diagnosis, pathophysiology, prevention and treatment. Conclusions from the 8th ECCO Scientific workshop.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
OP14 Risk of colorectal cancer diagnosis and colorectal cancer mortality in Crohn’s disease: A Scandinavian population-based cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP14: Effect of mirikizumab on clinical and endoscopic outcomes after 1 anti-TNF failure in patients with moderately to severely active Ulcerative Colitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
OP14: Extracellular RNAs as liquid biopsy non-invasive biomarker in IBD
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP14: Extracellular RNAs as liquid biopsy non-invasive biomarker in IBD
2021
ECCO'21 Virtual
Friday, 1 October 2021, 12:41 PM
OP14: Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP14: Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately-to-severely active ulcerative colitis: data from the U-ACHIEVE study
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
OP14: Interpreting genome-wide association studies of Inflammatory Bowel Disease through the lens of single-cell sequencing
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM